Growth features of aberrant crypt foci that resist modulation by cholic acid

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 2093-2096

  Shirtliff, N ^a   Bird, R P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CHOLIC ACID;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRUCTURE; COLON CARCINOGENESIS; CONTROLLED STUDY; CRYPT CELL; DIET; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 0029790864     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.2093     Document Type: Article

References (17)

1. Bird, R.P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151.
2. McLellan, E.A. and Bird, R.P. (1988) Specificity study to evaluate induction of aberrant crypts in murine colon. Cancer Res., 48, 6187-6192.
3. McLellan, E.A., Medline, A. and Bird, R.P. (1991) Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis, 12, 2093-2098.
4. Bird, R.P. (1995) Role of aberrant crypt foci in the understanding of the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
5. Pretlow, T.P., Barrow, B.B., Ashton, W.S., O'Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
6. Roncucci, L., Stamp, D., Medline, A., Cullen, J.B. and Bruce, W.R. (1991) Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Human Pathol., 22, 287-294.
7. Pretlow, T.P., Rrasitus, T.A., Fulton, N.C., Chayer, C. and Kaplan, F.I. (1993) K-ras mutations in putative preneoplastic lesions in human colon. J. Natl Cancer Inst., 85, 2004-2007.
8. Pretlow, T.P., O'Riordan, M.A., Pretlow, T.G. and Stellato, T.A. (1992) Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions. J. Cell. Biochem., 16G (Suppl.), 55-62.
9. Magnuson, B.A. and Bird, R.P. (1993) Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett., 68, 15-23.
10. Bird, R.P. (1995) Further investigation of the effect of cholic acid on the number and growth characteristics of aberrant crypt foci. Cancer Lett., 88, 201-209.
11. Magnuson, B.A., Carr, I. and Bird, R.P. (1993) Ability of aberrant crypt foci characteristics to predict colonic tumour incidence in rats fed cholic acid. Cancer Res., 53, 499-504.
12. McSherry, L.K., Cohen, B.E., Bokkenheuser, V.D., Mosbach, E.H., Winter, J., Matoba, N. and Scholes, J. (1989) Effect of calcium and bile acid feeding on colon tumours in the rat Cancer Res., 49, 6039-6043.
13. Corpet, D.E., Stamp, D., Medline, A., Minkin, S., Archer, M.C. and Bruce, W.R. (1990) Promotion of colonic microadenomas growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res., 50, 6955-6958.
14. Pretlow, T.P., O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512.
15. Magnuson, B.A., Shirtliff, N. and Bird, R.P. (1994) Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis, 15, 1459-1462.
16. Farber, E. and Rubin, H. (1991) Cellular adaptation in the origin and development of cancer. Cancer Res., 51, 2751-2761.
17. Bird, R.P. and Lafave, L.M.Z. (1994) Varying effects of dietary lipids and azoxymethane on early stages of colon Carcinogenesis: enumeration of aberrant crypt foci and proliferative indices. Cancer Detect. Prevent., 19, 308-315.